期刊文献+

羟基喜树碱在脂质体/水相中分配的影响因素研究 被引量:5

Study on Partition of Hydroxycamptothecin in the Phases of Liposome and Water
原文传递
导出
摘要 目的检测羟基喜树碱在脂质体/水相中的分配,考察影响分配的因素,探讨羟基喜树碱与脂质体膜的结合活化能。方法采取平衡透析法测定羟基喜树碱在脂质体/水相中的分配系数,考察了脂质体膜(磷脂种类、磷脂与胆固醇比例)、外界溶液pH值及离子强度对药物在脂质体/水相中分配的影响;根据表观分布平衡常数的自然对数(lnKapp)与绝对温度倒数(1/T)的直线斜率(-△G/R),计算药物分子和脂质体膜之间的结合活化能。结果随着脂质体膜的刚性增强,药物在脂质体膜中的分配降低;随着溶液中碱性增强(pH>4.0),药物在脂质体膜中分配逐渐降低;随着溶液中离子强度的增强,药物在脂质体膜中分配提高。药物与脂质体膜的结合活化能(△G)为-11.698kJ·mol-1。结论羟基喜树碱在脂质体中的分配受磷脂膜、溶液pH值、离子强度等的影响,药物与脂质体膜的结合为放热反应。 OBJECTIVE To determine the partition of hydroxycamptothecin in the phases of liposome and water and to evaluate the influence on the partition coefficients and binding Gibbs energy between the molecules of drug and water. METHODS Equilibrium dialysis technique was used to study the liposome/water partition coefficients of drug. The properties of liposome membrane (lipid species and the ratios of cholesterol),pH and ionic strength of medium were studied. The binding Gibbs energy (ΔG) was calculated according to the slope rate of the curve of lnKapp against 1/T. RESULTS The partition of drug in the phases of liposome and water decreased with the increase of membrane rigidity and pH of medium (when pH 4.0),while ionic strength showed the opposite effect on the partition. The binding Gibbs energy (ΔG) of the molecules of drug and liposome membrane was -11.698 kJ·mol^-1. CONCLUSION The partition of hydroxycamptothecin in liposome and water may be influenced by the liposome membrane,pH and ionic strength of the medium.
出处 《中国药学杂志》 CAS CSCD 北大核心 2009年第23期1796-1800,共5页 Chinese Pharmaceutical Journal
关键词 羟基喜树碱 脂质体/水相 分配 hydroxycamptothecin liposome/water partition
  • 相关文献

参考文献2

二级参考文献15

  • 1[2]Christian B. Homocamptothecins:potent topoisomerase I inhibitors and promising anticancer drugs[J]. Crit Rev Oncol Hematol, 2003 ;45( 1 ) :91 - 108
  • 2[3]Zhang RW, Li YF, Cai QY, Liu TP, Sun H. Preclinical pharmacology of the natural product anticancer agent 10-hydroxycamptothecin, an inhibitor of topoisomerase I [ J ]. Cancer Chemother Pharmacol, 1998; 41: 257 - 67
  • 3[7]Ma J, Liu CL, Zhu PL, Jia ZP, Xu LT, Wang R. Simultaneous determination of the carboxylate and lactone forms of 10hydroxycamptothecin in human serum by restricted-access media high-performance liquid chromatography [J]. J Chromatogr B,2002; 772:197 - 204
  • 4[8]Zhou J J, Liu Jn, Xu B. Relationship between lactone ring forms of hcpt and their antitumor activities[J]. 中国药理学报,2001;22(9) :827 - 30
  • 5[11]Li YF, Zhang RW. Reversed-phase high-performance liquid chromatography method for the simultaneous quantitation of the lactone and carboxylate forms of the novel natural product anticancer agent 10-hydroxycamptothecin in biological fluids and tissues[J]. J Chromatogr B, 1996;686:257- 65
  • 6[12]Bom D, Curran DP, Zhang J, Zimmer SG, Bevins R, Kruszewski S, et al. The highly lipophilic DNA topoisomerase I inhibitor DB-67 displays elevated lactone levels in human blood and potent anticancer activity [ J]. J Controlled Release, 2001; 74(6) :325 - 33
  • 7胥彬 杨金龙.抗肿瘤药物羟基喜树碱[J].医药工业,1985,16(2):22-22.
  • 8凌义和,俞伟娟,胥彬.10-羟基喜树碱对小鼠肝癌细胞转运嘧啶核苷的影响[J]Acta Biochimica et Biophysica Sinica,1983(06).
  • 9刘键.羟基喜树碱类药物作用机制及在合并治疗中机理的研究[J].中国肿瘤临床,1998,25(5):389-392. 被引量:162
  • 10路伟,张志荣,刘滨.高效液相色谱法测定兔血浆中羟基喜树碱的含量[J].广东药学,1999,9(4):55-57. 被引量:5

共引文献33

同被引文献53

引证文献5

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部